IRLAB Therapeutics AB (publ) (IRLAB-A.ST)

SEK 6.89

(-0.14%)

Long Term Debt Summary of IRLAB Therapeutics AB (publ)

  • IRLAB Therapeutics AB (publ)'s latest annual long term debt in 2023 was 24.51 Million SEK , up 6333.33% from previous year.
  • IRLAB Therapeutics AB (publ)'s latest quarterly long term debt in 2024 Q3 was - SEK , down -100.0% from previous quarter.
  • IRLAB Therapeutics AB (publ) reported annual long term debt of 381 Thousand SEK in 2022, down -89.32% from previous year.
  • IRLAB Therapeutics AB (publ) reported annual long term debt of 3.56 Million SEK in 2021, up 180.79% from previous year.
  • IRLAB Therapeutics AB (publ) reported quarterly long term debt of 2.59 Million SEK for 2024 Q2, down -89.81% from previous quarter.
  • IRLAB Therapeutics AB (publ) reported quarterly long term debt of - SEK for 2024 Q3, down -100.0% from previous quarter.

Annual Long Term Debt Chart of IRLAB Therapeutics AB (publ) (2023 - 2013)

Historical Annual Long Term Debt of IRLAB Therapeutics AB (publ) (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 24.51 Million SEK 6333.33%
2022 381 Thousand SEK -89.32%
2021 3.56 Million SEK 180.79%
2020 1.27 Million SEK -56.21%
2019 2.9 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK -100.0%
2016 400 Thousand SEK 0.0%
2015 400 Thousand SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%

Peer Long Term Debt Comparison of IRLAB Therapeutics AB (publ)

Name Long Term Debt Long Term Debt Difference
Active Biotech AB (publ) 3 Million SEK -717.033%
Biovica International AB (publ) 4.29 Million SEK -470.554%
Cantargia AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Cyxone AB (publ) 74 Thousand SEK -33022.973%
Diagonal Bio AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -1606.894%
Fluicell AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -2783.647%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Intervacc AB (publ) 142 Thousand SEK -17161.268%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 24.771%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 78.289%
Lipum AB (publ) 1.76 Million SEK -1291.88%
Alligator Bioscience AB (publ) 7.51 Million SEK -226.118%
Ziccum AB (publ) 286 Thousand SEK -8470.28%
BioArctic AB (publ) 2.15 Million SEK -1038.987%
Genovis AB (publ.) 74.8 Million SEK 67.235%
Camurus AB (publ) 13.61 Million SEK -80.056%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 23.276%
Kancera AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 62.428%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -5680.896%
Karolinska Development AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -2351.1%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 97.391%
Hansa Biopharma AB (publ) 844.9 Million SEK 97.099%
Biosergen AB - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -17922.794%
LIDDS AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 76.295%
BioInvent International AB (publ) 14.53 Million SEK -68.634%
SynAct Pharma AB 58 Thousand SEK -42160.345%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -2783.647%
Alzinova AB (publ) 800 Thousand SEK -2963.875%
Ascelia Pharma AB (publ) 176 Thousand SEK -13826.705%
Oncopeptides AB (publ) 106.48 Million SEK 76.982%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 72.988%
Diamyd Medical AB (publ) 30.67 Million SEK 20.087%